| Dr Richard Lee Stennes, MD | |
|
2533 Calle Del Oro, La Jolla, CA 92037-2005 | |
| (858) 459-4750 | |
| (858) 454-9345 |
| Full Name | Dr Richard Lee Stennes |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2533 Calle Del Oro, La Jolla, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194793919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C33379 (California) | Primary |
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532468 PECOS PAC ID: 4284546151 Enrollment ID: O20031209000264 |
News Archive
Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.
Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.
› Verified 7 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20031209000521 |
News Archive
Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.
Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.
› Verified 7 days ago
| Entity Name | Sanford Health Of Northern Minnesota |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770849697 PECOS PAC ID: 5597725168 Enrollment ID: O20041025000442 |
News Archive
Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.
Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.
› Verified 7 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20061104000649 |
News Archive
Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.
Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Lee Stennes, MD 2533 Calle Del Oro, La Jolla, CA 92037-2005 Ph: (858) 459-4750 | Dr Richard Lee Stennes, MD 2533 Calle Del Oro, La Jolla, CA 92037-2005 Ph: (858) 459-4750 |
News Archive
Loyola University Health System will partner with the Cook County Sheriff's Department to hold a medication take-back day.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
Simple changes in a family's lifestyle can stop chronic illnesses in children before they start. For 12-year-old Austin Stanfill, a makeover of his family's diet allowed him to prevent a type-2 diabetes diagnosis.
Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology & Hepatology.
› Verified 7 days ago
Mrs. Susan Elizabeth Mckim, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8646 Fax: 858-554-6271 | |
Dr. Monte Tim Mellon, M.D. M.B.A. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, La Jolla, CA 92037 Phone: 858-626-6150 Fax: 858-626-7117 | |
Richard M Obler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 354 Ricardo Pl, La Jolla, CA 92037 Phone: 858-922-1073 | |
Ian R Grover, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Drive, La Jolla, CA 92037 Phone: 858-657-7000 | |
Ian Reilly, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, La Jolla, CA 92037 Phone: 858-354-6049 | |
George R Baehr, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10710 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8638 | |
Sean X Neath, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7000 |